Ondine Biomedical Inc. (LON:OBI – Get Free Report)’s stock price traded up 3.5% during mid-day trading on Friday . The company traded as high as GBX 6.60 ($0.09) and last traded at GBX 6.60 ($0.09). 607 shares were traded during mid-day trading, a decline of 100% from the average session volume of 264,952 shares. The stock had previously closed at GBX 6.38 ($0.08).
Ondine Biomedical Price Performance
The company has a market capitalization of £18.30 million, a price-to-earnings ratio of -165.00 and a beta of 0.10. The company has a fifty day simple moving average of GBX 7.59 and a two-hundred day simple moving average of GBX 7.77. The company has a debt-to-equity ratio of 25.95, a quick ratio of 8.26 and a current ratio of 1.36.
Ondine Biomedical Company Profile
Ondine Biomedical Inc, a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens.
Featured Stories
- Five stocks we like better than Ondine Biomedical
- How to Evaluate a Stock Before Buying
- Powering Your Portfolio: The Utility Sector’s Electrifying Surge
- What Does Downgrade Mean in Investing?
- Adobe Stock Builds Long-Term Value: Consider Buying on the Dip
- 3 Fintech Stocks With Good 2021 Prospects
- Albemarle Jumps as Lithium Stock Buying Frenzy Takes Off
Receive News & Ratings for Ondine Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ondine Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
